๐ŸŽ—๏ธ OncologyInjection (SC)

    Epkinly

    Epcoritamab

    CD20-CD3 bispecific antibody administered subcutaneously for relapsed/refractory DLBCL.

    Form

    Injection (SC)

    Uses

    2

    Side effects

    5

    Category

    Oncology

    01

    What is Epkinly used for?

    • Relapsed/refractory diffuse large B-cell lymphoma
    • Large B-cell lymphoma
    02

    Epcoritamab side effects

    The following side effects have been reported for Epcoritamab. Their order does not indicate how often an effect occurs.

    Cytokine release syndrome
    Fatigue
    Injection site reactions
    Musculoskeletal pain
    ICANS
    03

    Epcoritamab warnings & precautions

    • Black box: CRS and neurologic toxicity (ICANS)
    • REMS program
    • Step-up dosing required

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Epkinly in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.